The Danish biotech firm is paying USD 9 million present moment to Boston-based Revitope Oncology in a collaboration that might set off turning point settlements to Revitope of as much as USD 600 million.
发布者:BY ALBERT RONNING-ANDERSSON,转转请注明出处:https://robotalks.cn/genmab-partners-with-us-oncology-firm-revitope/